Is BCT.TO undervalued or overvalued?

As of 2025-03-18, the Intrinsic Value of Briacell Therapeutics Corp (BCT.TO) is -22.37 CAD. This BCT.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.32 CAD, the upside of Briacell Therapeutics Corp is -520.40%. This means that BCT.TO is overvalued by 520.40%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-22.37 - -22.37	-22.37	-520.40%
P/E	5.37 - 5.37	5.37	0.9%
DDM - Stable	(30.79) - (102.95)	(66.87)	-1357.0%
DDM - Multi	(7.61) - (20.74)	(11.24)	-311.4%